Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Mar-Apr;15(3-4):95-100.
doi: 10.2119/molmed.2008.00118. Epub 2009 Dec 8.

High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer's disease patients

Laila Abdullah  1 , Cheryl Luis, Daniel Paris, Ghania Ait-ghezala, Benoit Mouzon, Elizabeth Allen, Julia Parrish, Myles A Mullan, Scott Ferguson, Marcie Wood, Fiona Crawford, Michael Mullan
Affiliations
Randomized Controlled Trial

High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer's disease patients

Laila Abdullah et al. Mol Med. 2009 Mar-Apr.

Abstract

The main objective of this study was to determine whether elevated blood beta-amyloid (Abeta) levels among the first-degree relatives of patients with Alzheimer's Disease (AD) are associated with vascular risk factors of AD. Serum Abeta was measured in samples from 197 cognitively normal first-degree relatives of patients with AD-like dementia. Study participants were recruited as part of an ancillary study of the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT subpopulation). The ADAPT subpopulation was found to be similar in age, sex, and ethnicity to another cognitively normal cohort (n = 98). Using cross-sectional analyses, we examined the association of Abeta with blood pressure, lipid levels, apolipoprotein E genotypes, and the use of prescribed medication to treat vascular risk factors in the ADAPT subpopulation. Abeta(1-40) was positively associated with age, use of antihypertensives, and serum creatinine, and we observed a marginal negative interaction on Abeta(1-40) associated with systolic blood pressure and use of antihypertensives. Serum Abeta(1-42) was associated with statin use and a positive correlation of Abeta (1-42) with HDL was observed among statin nonusers. These findings suggest that high Abeta in the periphery among the family history-enriched cohorts may be due to enrichment of vascular risk factors and may reflect presymptomatic AD pathology. It remains to be determined whether the association of Abeta with medications used for treating vascular risk factors indicates prevention of AD. Longitudinal evaluation of blood Abeta in this cohort will provide a better understanding of the significance of this association in AD etiology.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Median Aβ1–42 levels among statin nonusers is 12.03 pg/mL (interquartile range [IQR] 5.90–21.75 pg/mL), and median among statin users is 11.75 pg/mL (IQR 5.52–28.76 pg/mL).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Tandon A, Rogaeva E, Mullan M, St George-Hyslop PH. Molecular genetics of Alzheimer’s disease: the role of beta-amyloid and the presenilins. Curr Opin Neurol. 2000;13:377–84. - PubMed
    1. Mayeux R, et al. Plasma Aβ40 and Aβ42 and Alzheimer’s disease: relation to age, mortality, and risk. Neurology. 2003;61:1185–9. - PubMed
    1. Casoli T, et al. Release of beta-amyloid from high-density platelets: implications for Alzheimer’s disease pathology. Ann. N. Y. Acad. Sci. 2007;1096:170–8. - PubMed
    1. van Oijen M, Hofman A, Soares HD, Koudstaal PJ, Breteler MM. Plasma Aβ1–40 and Aβ1–42 and the risk of dementia: a prospective case-cohort study. Lancet Neurol. 2006;5:655–60. - PubMed
    1. Blasko I, et al. Conversion from cognitive health to mild cognitive impairment and Alzheimer’s disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine. Neurobiol Aging. 2008;29:1–11. - PubMed

Publication types

Substances